It was demonstrated that silencing the effects of β-arrestins in ETAR signaling decreases Src-EGFR-mediated transcriptional activity preventing β-arrestin-mediated ovarian cancer cell invasion and metastasis [163]. This evidence concerns the gene EDNRA and ovarian cancer.